Cargando…
Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
The World Health Organization (WHO) South-East Asia Regional Office (SEARO) covers 11 countries with a combined population of about 2 billion people, making it the most populous of the six WHO regions. In 1992, the WHO advocated including the hepatitis B vaccine in the Expanded Program of Immunizati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069988/ https://www.ncbi.nlm.nih.gov/pubmed/33921259 http://dx.doi.org/10.3390/vaccines9040374 |
_version_ | 1783683365934727168 |
---|---|
author | Akbar, Sheikh Mohammad Fazle Al Mahtab, Mamun Begum, Ferdousi Hossain, Shaikh A. Shahed Sarker, Sukumar Shrestha, Ananta Khan, Md. Sakirul Islam Yoshida, Osamu Hiasa, Yoichi |
author_facet | Akbar, Sheikh Mohammad Fazle Al Mahtab, Mamun Begum, Ferdousi Hossain, Shaikh A. Shahed Sarker, Sukumar Shrestha, Ananta Khan, Md. Sakirul Islam Yoshida, Osamu Hiasa, Yoichi |
author_sort | Akbar, Sheikh Mohammad Fazle |
collection | PubMed |
description | The World Health Organization (WHO) South-East Asia Regional Office (SEARO) covers 11 countries with a combined population of about 2 billion people, making it the most populous of the six WHO regions. In 1992, the WHO advocated including the hepatitis B vaccine in the Expanded Program of Immunization (EPI) and vaccinating all infants and children three times within 1 year of birth (HepB3). Recently, the WHO advocate birth-dose hepatitis B vaccination (HepB-BD) as soon as possible after birth, preferably within 24 hours. In 2016, the SEARO endorsed a regional hepatitis B control goal with a target of hepatitis B surface antigen (HBsAg) seroprevalence of ≤1% among children aged ≥5 years by 2020. Of the 11 SEARO countries, four achieved this target on schedule. Out of these four countries, two countries (Bangladesh and Nepal) have not adopted HepB-BD in EPI program. On the other hand, the coverage of HepB3 is not satisfactory in some SEARO countries, including India which adopted HepB-BD but could not achieve the overall target of SEARO. Thus, it is a point of debate whether emphasis should be placed on proper implementation of HepB3 or whether a new agenda of HepB-BD should be incorporated in developing countries of SEARO. The article discusses strengthening and expanding the Hepatitis B vaccination program in SEARO countries with an emphasis on HepB and HepB-BD programs. |
format | Online Article Text |
id | pubmed-8069988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80699882021-04-26 Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia Akbar, Sheikh Mohammad Fazle Al Mahtab, Mamun Begum, Ferdousi Hossain, Shaikh A. Shahed Sarker, Sukumar Shrestha, Ananta Khan, Md. Sakirul Islam Yoshida, Osamu Hiasa, Yoichi Vaccines (Basel) Review The World Health Organization (WHO) South-East Asia Regional Office (SEARO) covers 11 countries with a combined population of about 2 billion people, making it the most populous of the six WHO regions. In 1992, the WHO advocated including the hepatitis B vaccine in the Expanded Program of Immunization (EPI) and vaccinating all infants and children three times within 1 year of birth (HepB3). Recently, the WHO advocate birth-dose hepatitis B vaccination (HepB-BD) as soon as possible after birth, preferably within 24 hours. In 2016, the SEARO endorsed a regional hepatitis B control goal with a target of hepatitis B surface antigen (HBsAg) seroprevalence of ≤1% among children aged ≥5 years by 2020. Of the 11 SEARO countries, four achieved this target on schedule. Out of these four countries, two countries (Bangladesh and Nepal) have not adopted HepB-BD in EPI program. On the other hand, the coverage of HepB3 is not satisfactory in some SEARO countries, including India which adopted HepB-BD but could not achieve the overall target of SEARO. Thus, it is a point of debate whether emphasis should be placed on proper implementation of HepB3 or whether a new agenda of HepB-BD should be incorporated in developing countries of SEARO. The article discusses strengthening and expanding the Hepatitis B vaccination program in SEARO countries with an emphasis on HepB and HepB-BD programs. MDPI 2021-04-12 /pmc/articles/PMC8069988/ /pubmed/33921259 http://dx.doi.org/10.3390/vaccines9040374 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Akbar, Sheikh Mohammad Fazle Al Mahtab, Mamun Begum, Ferdousi Hossain, Shaikh A. Shahed Sarker, Sukumar Shrestha, Ananta Khan, Md. Sakirul Islam Yoshida, Osamu Hiasa, Yoichi Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia |
title | Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia |
title_full | Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia |
title_fullStr | Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia |
title_full_unstemmed | Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia |
title_short | Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia |
title_sort | implications of birth-dose vaccination against hepatitis b virus in southeast asia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069988/ https://www.ncbi.nlm.nih.gov/pubmed/33921259 http://dx.doi.org/10.3390/vaccines9040374 |
work_keys_str_mv | AT akbarsheikhmohammadfazle implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia AT almahtabmamun implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia AT begumferdousi implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia AT hossainshaikhashahed implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia AT sarkersukumar implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia AT shresthaananta implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia AT khanmdsakirulislam implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia AT yoshidaosamu implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia AT hiasayoichi implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia |